Provided by Tiger Trade Technology Pte. Ltd.

Ecopetrol SA

11.62
-0.0700-0.60%
Volume:959.17K
Turnover:11.23M
Market Cap:23.89B
PE:8.23
High:11.84
Open:11.59
Low:11.56
Close:11.69
52wk High:13.27
52wk Low:7.80
Shares:2.06B
Float Shares:233.42M
Volume Ratio:0.51
T/O Rate:0.41%
Dividend:0.99
Dividend Rate:8.53%
EPS(TTM):1.41
EPS(LYR):1.65
ROE:14.61%
ROA:6.46%
PB:1.23
PE(LYR):7.05

Loading ...

Press Release: Ecopetrol S.A. has obtained authorization to execute a loan with local financial institutions for COP 700,000 million, under a committed credit line structure

Dow Jones
·
Oct 24, 2025

Rhythm Pharmaceuticals to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

GlobeNewswire
·
Oct 22, 2025

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer

GlobeNewswire
·
Oct 18, 2025

Further weakness as EC Healthcare (HKG:2138) drops 14% this week, taking five-year losses to 85%

Simply Wall St.
·
Oct 18, 2025

Novartis Scemblix® receives positive CHMP opinion for the treatment of adults with newly diagnosed CML

GlobeNewswire
·
Oct 17, 2025

Novartis Fabhalta® (iptacopan) meets Phase III primary endpoint, slows kidney function decline in patients with IgA nephropathy (IgAN)

GlobeNewswire
·
Oct 16, 2025

Press Release: Ecopetrol S.A. Board of Directors Announcements

Dow Jones
·
Oct 16, 2025

Listed Company's 125 Million Yuan Generic Drug Application Rejected as Original Drug "Crashes": Withdrawn from European and US Markets Due to Safety Issues

Deep News
·
Oct 14, 2025

Major Stock Purchase by EC John Mazarakis in Chicago Atlantic Real Estate!

TIPRANKS
·
Oct 03, 2025

Jakarta Prosecutor Transfers 9 Pertamina Corruption Suspects to Court

Tempo
·
Oct 01, 2025

Eli Lilly says EC grants marketing authorization for Kisunla

TIPRANKS
·
Sep 26, 2025

EC World REIT Updates on Forchn Holdings Reorganization Efforts

TIPRANKS
·
Sep 25, 2025

New Data for BRIUMVI® Demonstrate 89.9% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 6 Years of Continuous BRIUMVI Treatment

GlobeNewswire
·
Sep 24, 2025

Kelun-Biotech to Present Results from Multiple Clinical Studies at the 2025 ESMO Congress

prnewswire
·
Sep 23, 2025

Market Chatter: Ecopetrol Eyes Petrobras' Bahia Terra Cluster in Brazil

MT Newswires Live
·
Sep 19, 2025

European Commission (EC) Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

prnewswire
·
Sep 19, 2025

Organon, Shanghai Henlius: EC approves marketing for Bildyos, Bilprevda

TIPRANKS
·
Sep 19, 2025

Audi Debuts First E5 Sportback with Ambilight's Electrochromic Smart Dimming Sunroof

prnewswire
·
Sep 18, 2025

Biogen receives EC approval for Zurzuvae

TIPRANKS
·
Sep 18, 2025

Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe

GlobeNewswire
·
Sep 18, 2025